We are live on ! Find out more
NGNE icon

Neurogene
NGNE

19 hedge funds and large institutions have $41.1M invested in Neurogene in 2014 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 6 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

17% less funds holding

Funds holding: 23 → 19 (-4)

31% less capital invested

Capital invested by funds: $59.6M → $41.1M (-$18.5M)

50% less repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 6

67% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 6

Holders
19
Holders Change
-4
Holders Change %
-17.39%
% of All Funds
0.54%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
3
Reduced
6
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Franklin Resources
Franklin Resources
California
+$1.06M
2
CAM
Cormorant Asset Management
Massachusetts
+$512K
3
Alyeska Investment Group
Alyeska Investment Group
Illinois
+$99.7K
4
TRCT
Tower Research Capital (TRC)
New York
+$9.65K

Top Sellers

Rank Fund Capital Flow
1
DCM
Driehaus Capital Management
Illinois
-$1.72M
2
Jennison Associates
Jennison Associates
New York
-$955K
3
HCMT
Highland Capital Management (Texas)
Texas
-$869K
4
DM
Deerfield Management
New York
-$794K
5
SAM
Sectoral Asset Management
Quebec, Canada
-$382K

NGNE Hedge Fund Activity: Q2 2014 in Review

19 of the 3,491 institutional investors tracked by Wall St. Rank reported a position in Neurogene (NGNE) for Q2 2014, worth a combined $41.1M — down 31% from $59.6M a quarter earlier.

Sellers outnumbered buyers: 6 funds closed out of NGNE and 2 opened new positions — a net loss of 4 holders — while 6 trimmed existing stakes and 3 added.

The largest buyer was Franklin Resources, adding an estimated $1.06M. The largest seller was Driehaus Capital Management, cutting an estimated $1.72M.

  • 19 institutional investors held Neurogene (NGNE) as of Q2 2014, down from 23 in Q1 2014.
  • Funds reported $41.1M of Neurogene stock for Q2 2014, down 31% quarter-over-quarter.
  • 2 funds opened new Neurogene positions in Q2 2014 and 6 closed out, a net change of -4 holders.
  • The largest Neurogene buyer in Q2 2014 was Franklin Resources, an estimated $1.06M added.
  • The largest Neurogene seller in Q2 2014 was Driehaus Capital Management, an estimated $1.72M sold.

Based on aggregated 13F filings for Q2 2014.